NUVB
Nuvation Bio Inc.stockNYSE
Market OpenNov 19, 2026 9:46:11 AM EST
3.86USD+1.984%(+0.08)564,663
Pre-marketNov 19, 2026 9:07:30 AM EST
3.82USD+1.058%(+0.04)
NUVB Financials
In Q3 FY 2026 (ended ), Nuvation Bio Inc. (NUVB) reported revenue of $44.95M, net income of −$41.9M, operating cash flow of −$38.56M, and assets of $778.39M (filed ).
Loading financial statements…